Revance Therapeutics Inc (RVNC)

[iwfal]

Jeuveau Extra-Strength results - further comments:

One of the meaningful differences in the Extra Strength trial was less than half the normal number of men (about 14% in ph3, about 6% here). Given that they were testing fixed doses... this would mean longer duration. Not likely to be huge effect given a difference of only 8%, but not minor either. (Comment: I'd wager this was intentional since it is out of family for the ph3's in Glabellar, which are normally at least 10% and typically 12 to 20%.)

Comment: assuming an undiscounted price per 100 unit vial of ~$600, Daxi is significantly cheaper for the same duration.